TranS1

About:

TranS1 develops a portfolio of medical products and intellectual property in the area of advanced surgical medicine.

Twitter/X: trans1

Top Investors: Advanced Technology Ventures, Delphi Ventures, Cutlass Capital, Sapient Capital Partners

Description:

TranS1 develops a portfolio of medical products and intellectual property in the area of advanced surgical medicine. It began operation in 2002. TranS1 has its headquarters in Denver in Colorado. It operates as a subsidiary of The Quandary Group.

Total Funding Amount:

$12M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Denver, Colorado, United States

Founded Date:

2002-01-01

Contact Email:

contact(AT)trans1.com

Founders:

George Wallace, Jeffrey Schell

Number of Employees:

11-50

Last Funding Date:

2003-05-12

IPO Status:

Private

Industries: